All Press Releases

Yumanity Therapeutics Closes $45 Million Series A Financing February 10, 2016

Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline January 26, 2016

Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda Pharmaceuticals To Advance New Therapies in ALS December 21, 2015

Navitor Pharmaceuticals Announces $33 Million Series B Financing December 18, 2015

Arsia Therapeutics Inc. and Biogen Sign a Research Collaboration for the Development of Subcutaneous Biologics December 16, 2015

Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma December 14, 2015

Aquinnah Pharmaceuticals Receives $680,000 Grant from NINDS To Advance New Therapies for ALS November 23, 2015

Jackson Laboratory Spinout Cyteir Therapeutics Announces $5.5 Million Series A Financing Round and Appointment of Donald F. Corcoran as President and Chief Executive Officer November 5, 2015

Affinivax Announces Collaboration with ClearPath and Astellas to Develop Vaccines to Prevent Nosocomial Infections October 26, 2015

Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer October 21, 2015

1 ... 16 17 18 ... 21